Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents

Paz Toren, Sharon Ratner, Nathaniel Laor, Abraham Weizman

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents'. Together they form a unique fingerprint.

Chemistry

Medicine & Life Sciences